ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.74141
0.23%
Brent Oil
84.34
-0.30%
Bitcoin
63,999.24
5.29%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) Noticias

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
24/08/202215:15TipRanksConcert Pharma (CNCE) Receives a New Rating from JonesTradingNASDAQ:CNCEConcert Pharmaceuticals Inc
22/08/202206:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
22/08/202206:05Business WireConcert Pharmaceuticals Announces That Results From CTP-543 THRIVE‑AA1 Phase 3 Trial in Patients With Alopecia Areata Selected for Late Breaking Presentation at EADV CongressNASDAQ:CNCEConcert Pharmaceuticals Inc
22/08/202206:00Business WireConcert Pharmaceuticals Announces Exercise of Warrants Under Existing Financing ArrangementNASDAQ:CNCEConcert Pharmaceuticals Inc
05/08/202205:41TipRanksConcert Pharma (CNCE) Receives a Buy from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
04/08/202212:55TipRanksAnalysts Offer Insights on Healthcare Companies: BioCryst (BCRX) and Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
04/08/202206:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
04/08/202206:00Business WireConcert Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
01/08/202211:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/08/202206:00Business WireConcert Pharmaceuticals Reports Positive Topline Results for Second CTP‑543 Phase 3 Clinical Trial in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
29/07/202206:00Business WireConcert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
13/06/202215:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
09/06/202206:00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
07/06/202206:00Business WirePhase 2 Dose‑Ranging Clinical Trial Results of CTP‑543 in Patients with Alopecia Areata published in the Journal of the American Academy of DermatologyNASDAQ:CNCEConcert Pharmaceuticals Inc
06/06/202215:01Business WireConcert Pharmaceuticals Raises Gross Proceeds of $66.4 Million Through Public Offering and Exercise of WarrantsNASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202205:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/06/202218:55Business WireConcert Pharmaceuticals Announces Pricing of Public OfferingNASDAQ:CNCEConcert Pharmaceuticals Inc
31/05/202215:01Business WireConcert Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:CNCEConcert Pharmaceuticals Inc
23/05/202209:05TipRanksConcert Pharma (CNCE) Receives a Buy from JMP SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
23/05/202208:55TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
23/05/202208:25TipRanksMizuho Securities Reaffirms Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
23/05/202206:00Business WireConcert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
12/05/202211:15TipRanksAnalysts Offer Insights on Healthcare Companies: Concert Pharma (CNCE) and Cullinan Management (CGEM)NASDAQ:CNCEConcert Pharmaceuticals Inc
12/05/202208:25TipRanksConcert Pharma (CNCE) Received its Third Buy in a RowNASDAQ:CNCEConcert Pharmaceuticals Inc
06/05/202205:29TipRanksConcert Pharma (CNCE) Gets a Buy Rating from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
05/05/202206:00Business WireConcert Pharmaceuticals Reports First Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
28/04/202206:00Business WireConcert Pharmaceuticals to Report First Quarter 2022 Results on May 5, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
26/04/202206:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
24/04/202219:45TipRanksConcert Pharma (CNCE) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
14/04/202206:08Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
NYSE
BAC
Bank of America
AMEX
XLV
Health Care Select Sector
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
CCOM
OILBRENT
Brent Oil
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados